Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women

Human Reproduction

Volumn 22, Issue 6, 2007, Pages 1547-1554

  Kevenaar, Marlies E ^a   Themmen, Axel P N ^a   Laven, Joop S E ^a   Sonntag, Barbara ^b   Fong, Sharon Lie ^a   Uitterlinden, André G ^a   de Jong, Frank H ^a   Pols, Huibert A P ^a   Simoni, Manuela ^b   Visser, Jenny A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Anti M llerian hormone; Estrogen; Menstrual cycle; Ovarian function; Polymorphism

Indexed keywords

ESTRADIOL; FOLLITROPIN; HORMONE RECEPTOR; ISOLEUCINE; MUELLERIAN INHIBITING FACTOR; MUELLERIAN INHIBITING FACTOR TYPE 2; SERINE; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CELL LEVEL; CELL MIGRATION; COHORT ANALYSIS; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; FOLLITROPIN BLOOD LEVEL; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GERMANY; HETEROZYGOTE; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE SENSITIVITY; HUMAN; HYPOTHESIS; MENSTRUAL CYCLE; NETHERLANDS; NORMAL HUMAN; OVARY FUNCTION; OVULATION;

MUS;

EID: 34447324655     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dem036     Document Type: Article

References (40)

1. Andersen CY and Byskov AG (2006) Estradiol and regulation of anti-mullerian hormone, inhibin-a, and inhibin-B secretion: Analysis of small antral and preovulatory human follicles' fluid. J Clin Endocrinol Metab 91,4064-4069.
2. Carlsson IB, Scott JE, Visser JA, Ritvos O, Themmen AP and Hovatta O (2006) Anti-Mullerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro. Hum Reprod 21,2223-2227.
3. de Castro F, Moron FJ, Montoro, L, Galan JJ, Hernandez DP, Padilla ES, Ramirez-Lorca R, Real LM and Ruiz A (2004) Human controlled ovarian hyperstimulation outcome is a polygenic, trait. Pharmacogenetics 14,285-293.
4. di Clemente N, Goxe B, Remy JJ, Cate R, Josso N, Vigier B and Salesse R (1994) Inhibitory effect of AMH upon the expression of aromatase and LH receptors by cultured granulosa cells of rat and porcine immature ovaries. Endocrine 2,553-558.
5. van Dessel HJ, Schipper I, Pache TD, van Geldorp H, de Jong FH and Fauser BCJM (1996) Normal human follicle development: An evaluation of correlations with oestradiol, androstenedione and progesterone levels in individual follicles. Clin Endocrinol (Oxf) 44,191-198.
6. Durlinger ALL, Kramer P, Karels B, de Jong FH, Uilenbroek JTJ, Grootegoed JA and Themmen APN (1999) Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology 140,5789-5796.
7. Durlinger ALL, Gruijters MJG, Kramer P, Karels B, Kumar TR, Matzuk MM, Rose UM, de Jong FH, Uilenbroek JTJ, Grootegoed JA, et al. (2001) Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 142,4891-4899.
8. Durlinger ALL, Visser JA and Themmen APN (2002) Regulation of ovarian function: The role of anti-Mullerian hormone. Reproduction 124,601-609.
9. Fauser BCJM and Van Heusden AM (1997) Manipulation of human ovarian function: Physiological concepts and clinical consequences. Endocr Rev 18,71-106.
10. Fauser BC, Pache TD, Lamberts SW, Hop WC, de Jong FH and Dahl KD (1991) Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease. J Clin Endocrinol Metab 73,811-817.
11. Greb RR, Grieshaber K, Gromoll J, Sonntag B, Nieschlag E, Kiesel L and Simoni M (2005) A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab 90,4866-4872.
12. Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mather JP and McNeilly AS (1996) Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 81,1401-1405.
13. Hillier SG, Reichert LE Jr and Van Hall EV (1981) Control of preovulatory follicular estrogen biosynthesis in the human ovary. J Clin Endocrinol Metab 52,847-856.
14. Hohmann FP, Laven JSE, de Jong FH, Eijkemans MJC and Fauser BCJM (2001) Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development. Hum Reprod 16,846-854.
15. Kevenaar ME, Meerasahib MF, Kramer P, van de Lang-Born BMN, de Jong FH, Groome NP, Themmen APN and Visser JA (2006) Serum AMH levels reflect the size of the primordial follicle pool in mice. Endocrinology 147,3228-34.
16. Landgren BM, Unden AL and Diczfalusy E (1980) Hormonal profile of the cycle in 68 normally menstruating women. Acta Endocrinol (Copenh) 94,89-98.
17. Laven JSE and Fauser BCJM (2006) What role of estrogens in ovarian stimulation. Maturitas 54,356-362.
18. Laven JSE, Imani B, Eijkemans MJC and Fauser BCJM (2002) New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv 57,755-767.
19. Laven JSE, Mulders AGMGJ, Visser JA, Themmen APN, De Jong FH and Fauser BCJM (2004) Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 89,318-323.
20. Macklon NS and Fauser BCJM (2001) Follicle-stimulating hormone and advanced follicle development in the human. Arch Med Res 32,595-600.
21. McGee EA and Hsueh AJ (2000) Initial and cyclic recruitment of ovarian follicles. Endocr Rev 21,200-214.
22. Mulders AG, Eijkemans MJ, Imani B and Fauser BC (2003) Prediction of chances for success or complications in gonadotrophin ovulation induction in normogonadotrophic anovulatory infertility. Reprod Biomed Online 7,170-178.
23. Nagata C, Kaneda N, Kabuto M and Shimizu H (1997) Factors associated with serum levels of estradiol and sex hormone-binding globulin among premenopausal Japanese women. Environ Health Perspect 105,994-997.
24. Newton-Cheh C and Hirschhorn JN (2005) Genetic association studies of complex traits: Design and analysis issues. Mutat Res 573,54-69.
25. Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S and Dewailly D (2003) Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: Relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 88,5957-5962.
26. Rivadeneira F, van Meurs JB, Kant J, Zillikens MC, Stolk L, Beek TJ, Arp P, Schuit SC, Hofman A, Houwing-Duistermaat JJ, et al. (2006) Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGFI) variants influence the risk of fracture in postmenopausal women. J Bone Miner Res 21,1443-1456.
27. van Rooij IAJ, Broekmans FJM, te Velde ER, Fauser BCJM, Bancsi LF, de Jong FH and Themmen APN (2002) Serum anti-Mullerian hormone levels: A novel measure of ovarian reserve. Hum Reprod 17,3065-3071.
28. van Santbrink EJP, Hop WCJ, van Dessel TJ, de Jong FH and Fauser BCJM (1995) Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. Fertil Steril 64,37-43.
29. Schipper I, de Jong FH and Fauser BCJM (1998) Lack of correlation between maximum early follicular phase serum follicle stimulating hormone concentrations and menstrual cycle characteristics in women under the age of 35 years. Hum Reprod 13,1442-1448.
30. Short RV (1962) Steroids in the follicular fluid and the corpus luteum of the mare. A 'two-cell type' theory of ovarian steroid synthesis. J Endocrinol 24,59-63.
31. Simoni M, Gromoll J, Hoppner W, Kamischke A, Krafft T, Stahle D and Nieschlag E (1999) Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal and infertile men: Identification and characterization of two discrete FSH receptor isoforms. J Clin Endocrinol Metab 84,751-755.
32. Stephens M and Donnelly P (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73,1162-1169.
33. Stephens M, Smith NJ and Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68,978-989.
34. The International HapMap Project (2003) Nature 426,789-796.
35. de Vet A, Laven JSE, de Jong FH, Themmen APN and Fauser BCJM (2002) Antimullerian hormone serum levels: A putative marker for ovarian aging. Fertil Steril 77,357-362.
36. Visser JA, de Jong FH, Laven JSE and Themmen APN (2006) Anti-Mullerian hormone: A new marker for ovarian function. Reproduction 131,1-9.
37. Welt CK and Schneyer AL (2001) Differential regulation of inhibin B and inhibin A by follicle-stimulating hormone and local growth factors in human granulosa cells from small antral follicles. J Clin Endocrinol Metab 86,330-336.
38. Welt CK, Adams JM, Sluss PM and Hall JE (1999) Inhibin A and inhibin B responses to gonadotropin withdrawal depends on stage of follicle development. J Clin Endocrinol Metab 84,2163-2169.
39. Welt CY, Smith ZA, Pauler DK and Hall JE (2001) Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development. J Clin Endocrinol Metab 86,2531-2537.
40. Windham GC, Elkin E, Fenster L, Waller K, Anderson M, Mitchell PR, Lasley B and Swan SH (2002) Ovarian hormones in premenopausal women: variation by demographic, reproductive and menstrual cycle characteristics. Epidemiology 13,675-13,684.